• DIN-Report-BannerV2
Enter Your Information Below to Receive Free Trading Ideas, Videos, and Articles.
*First Name:


REALLY? (What should not be surprising about the BABA IPO)

Since our Market Tamer readers are among the Crème de la crème (you are the “Cream of the Cream”!), I am quite certain that there are days when, as you hear or read the news, you shake your head and mutter: “You’ve got to be kidding me? Really?!!”

Netflix Continues to Grow, both Financially and Geographically

The European invasion of Netflix is not the only success the company has to celebrate. CNN Money reports that the media streaming giant is also in line to tie the market value of TV’s most watched network.

Bankruptcy Could Be RadioShack’s Next Broadcast

RadioShack seems to be epitomizing just what its name claims: a shack. A poorly constructed hut or cabin. The company is on the brink of collapsing, with bankruptcy proceeding possibly being filed as soon as November 1 of this year.

Has ISIS Spread Fear to U.S. Investors?

ISIS, ISIL, or the Islamic State? Doesn’t matter, as far as the stock market is concerned. Despite taking over the media’s news coverage and replacing Al Qaeda as the new face of fear, the terrorist organization has not shaken investors, because oil prices haven’t been bothered by them either.

Medtronic (MDT) Offering Possible 7.3% Return Over the Next 9 Calendar Days

Medtronic’s most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $65.50 short put and a strike $60.50 long put offers a potential 7.3% return on risk over the next 9 calendar days.

[Video] I see interest rates around 1% (find out when this will go into effect)

In today's Monday Market Outlook, WCI's Chief Investment Strategist Matthew 'Whiz' Buckley discusses futures looking up this week, a volatile Middle East, and the markets breathing a sign of relief as we come up from last week’s slew of macroeconomic data.

[Video] Making $1,900 in 5 Days Sure Beats a Stick in the Eye

In today's Friday Market Wrap-Up, WCI's Chief Investment Strategist Matthew 'Whiz' Buckley gives a macroeconomic overview – non-farm payroll, unemployment ticking up, construction spending plunging, and good news from China.

[Video] S&P Reaching the ‘Magnetic’ 2000 Mark, What Will Happen Next?

In today's Monday Market Outlook, Wealth Creation Investing's Chief Investment Strategist Matthew 'Whiz' Buckley discusses the huge week ahead for macroeconomic data. On Tuesday, we’ll see the Conference Board’s consumer confidence numbers, which has great market moving potential. However, Friday will literally be a shotgun blast of macroeconomic data.

[Video] The Dow Suffers Triple Digit Losses… Thanks Visa!

In today's Friday Market Wrap Up, Wealth Creation Investing's Chief Investment Strategist Matthew 'Whiz' Buckley discusses the Dow facing triple digit losses on Visa, NASDAQ down on Amazon, and why durable goods suffered a 1.6% Y/Y drop.

[Video] Good News Coming From China As Things Worsen In Ukraine

In today's Market Situation Report, Wealth Creation Investing's Chief Investment Strategist Matthew 'Whiz' Buckley discusses the new home sales collapsing 20%, the U.S. manufacturing PMI's biggest miss on record, and a huge dump in gold at the open.

Thinking To Buy Gold? Think OUNZ…

Let me emphasize that the investment "need" I have in mind today pales in comparison to any human need that is life threatening. However, this particular need does receive a lot of attention in the financial press and is frequently on the minds of investors within the precious metals markets!

Financial News
LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the... [...]
Mon, May 26, 2014
LONDON (Reuters) - Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British... [...]
Wed, May 21, 2014
LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, puncturing the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals... [...]
Mon, May 19, 2014
LONDON (Reuters) - U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if... [...]
Sun, May 18, 2014